Diagnostic and prognostic value of tumorspecific markers (CD117, DOG1, CD34, PDGFR-α), indicators of muscle (SMA, MSA, desmin) and fat (S100) differentiation, expression of Ki-67, p16, p21 in gastrointestinal stromal tumors.

Authors

  • V. R. Skoryk ДЗ «Дніпропетровська медична академія МОЗ України», Ukraine

DOI:

https://doi.org/10.26641/1997-9665.2015.3.74-82

Keywords:

gastrointestinal stromal tumor, diagnostic, malignancy potential, immunohistochemistry

Abstract

Background. Verification of gastrointestinal stromal tumors and determination of their malignancy potential remain still relevant. Objective. To identify relationships between clinical, histological and immunomorphological (СD117, DOG1, CD34, PDGFR-α, SMA, MSA, desmin, S100, Ki-67, p16, p21) characteristics of gastrointestinal stromal tumors. Methods. Our study included 50 gastroinestinal stromal tumors, which were divided into subgroups according to clinical (localization), morphological (histological features, morphological variation, the number of mitosis) characteristics depending on the presence of the expression of above mentioned markers. Statistical analysis of data included nonparametric tests. Results. Expression of CD117, DOG1, CD34, PDGFR-α, SMA, desmin, p16, p21 was specified in 94%, 90%, 76%, 61,1%, 24%, 50%, 46,6%, and 47% of cases, respectively. MSA, S100 positive tumors were revealed in 4% and 8% of all cases, and did not let us to divide them into subgroups. The one third of all cases had high expression of Ki-67. Conclusion. Ki-67 is a useful marker for determination of malignancy potential of GIST and significantly correlated with the number of mitosis and cellularity. Ki-67 expression is associated with the presence of p16 staining, it indicates the possibility of using these markers to define malignancy potential of GIST. Markers (CD117, DOG1, CD34, PDGFRα, SMA, p21) did not have prognostic value and were unrelated. There was relationship between the presence of PDGFRα staining and character of CD117 expression. CD117, DOG1 were highly sensitive markers, CD34, PDGFRα were useful markers during verification of GIST, but were less sensitive. Markers SMA, desmin, MSA, S100 are important for the diagnostic process.

References

  1. Bosman FT, Carneiro F, Hruban RH, Theise ND, authors. WHO classification of tumours of the digestive system. 4th. Lyon: IARC Press; 2010. 417 p.
  2. Dabbs DJ, author. Diagnostic immunohistochemistry. 4th ed. PA: Elsevier; 2013. 960 p.
  3. Fletcher C.D.M., author. Diagnostic histopathology of tumors. 4th ed. PA: Elsevier; 2013. 1148 p.
  4. Odze RD, Goldblum JR, Crawford JM, authors. Surgical pathology of the GI tract, liver, biliary tract, and pancreas. PA: Elsevier Health Sciences; 2004. 1067 p.
  5. Jung SH, Suh KS, Kang DY, Kang DW, Kim YB, Kim ES. Expression of DOG1, PDGFRA, and p16 in gastrointestinal stromal tumors. Gut and liver. 2011;5(2):171-180. DOI: 10.5009/gnl.2011.5.2.171. PMID: 21814597.
  6. Vij M, Agrawal V, Kumar A, Pandey R. Gastrointestinal stromal tumors: a clinicopathological and immunohistochemical study of 121 cases. Indian Journal of Gastroenterology. 2010;29(6):231-236. DOI: 10.4103/0970-9371.107505. PMID: 21221881.
  7. Belev B, Brčić I, Prejac J, Golubić Z A, Vrbanec D, Božikov J, Razumović JJ. Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors. World journal of gastroenterology. 2013;19(4):523. DOI:10.3748/wjg.v19.i4.523. PMID: 23382631.
  8. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23(2):70–8. PMID: 17193820.
  9. Wada T, Tanabe S, Ishido K, Higuchi K, Sasaki T, Katada C, Mikami T. DOG1 is useful for diagnosis of KIT-negative gastrointestinal stromal tumor of stomach. World journal of gastroenterology. 2013;19(47):9133. DOI: 10.3748/wjg.v19. i47.9133. PMID: 24379641.
  10. Ríos-Moreno MJ, Jaramillo S, Gallardo SP, Vallejo A, Mora M, García-Escudero González-Cámpora R. Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Pathology-Research and Practice. 2012;208(2):74-81. DOI: 10.1016/j.prp.2011.11.006. PMID: 22197035.
  11. Nielsen JS, McNagny KM. Novel functions of the CD34 family. Journal of cell science. 2008;121(22):3683-3692. DOI: 10.1242/jcs.037507. PMID: 18987355.
  12. Terada T. Gastrointestinal stromal tumor of the digestive organs: a histopathologic study of 31 cases in a single Japanese institute. International journal of clinical and experimental pathology. 2010;3(2):162. PMID: 20126584.

Downloads

How to Cite

Skoryk, V. R. (2015). Diagnostic and prognostic value of tumorspecific markers (CD117, DOG1, CD34, PDGFR-α), indicators of muscle (SMA, MSA, desmin) and fat (S100) differentiation, expression of Ki-67, p16, p21 in gastrointestinal stromal tumors. Морфологія / Morphologia / Morfologìâ, 9(3), 74–82. https://doi.org/10.26641/1997-9665.2015.3.74-82

Issue

Vol. 9 No. 3 (2015)

Section

Статті

License

Copyright (c) 2018 Morphologia

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

 The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.
        By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world. 
        The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.